Annual CFO
-$21.66 M
+$18.10 M+45.52%
31 December 2023
Summary:
NRx Pharmaceuticals annual cash flow from operations is currently -$21.66 million, with the most recent change of +$18.10 million (+45.52%) on 31 December 2023. During the last 3 years, it has fallen by -$19.39 million (-856.16%). NRXPW annual CFO is now -2631.95% below its all-time high of -$792.73 thousand, reached on 31 December 2019.NRXPW Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$2.31 M
+$256.00 K+9.99%
30 September 2024
Summary:
NRx Pharmaceuticals quarterly cash flow from operations is currently -$2.31 million, with the most recent change of +$256.00 thousand (+9.99%) on 30 September 2024. Over the past year, it has increased by +$2.26 million (+49.47%). NRXPW quarterly CFO is now -108.73% below its all-time high of $26.40 million, reached on 31 December 2021.NRXPW Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$11.73 M
+$2.26 M+16.14%
30 September 2024
Summary:
NRx Pharmaceuticals TTM cash flow from operations is currently -$11.73 million, with the most recent change of +$2.26 million (+16.14%) on 30 September 2024. Over the past year, it has dropped by -$7.17 million (-157.03%). NRXPW TTM CFO is now -203.31% below its all-time high of $11.36 million, reached on 31 December 2021.NRXPW TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NRXPW Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +45.5% | +49.5% | -157.0% |
| 3 y3 years | -856.2% | +80.8% | +23.5% |
| 5 y5 years | - | -4308.0% | -2110.7% |
NRXPW Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -856.2% | +45.5% | -108.7% | +84.4% | -203.3% | +23.5% |
| 5 y | 5 years | -2631.9% | +45.5% | -108.7% | +84.4% | -203.3% | +23.5% |
| alltime | all time | -2631.9% | +45.5% | -108.7% | +84.4% | -203.3% | +23.5% |
NRx Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.31 M(-10.0%) | -$11.73 M(-16.1%) |
| June 2024 | - | -$2.56 M(-30.2%) | -$13.99 M(+22.4%) |
| Mar 2024 | - | -$3.67 M(+15.0%) | -$11.43 M(+47.3%) |
| Dec 2023 | -$21.66 M(-45.5%) | -$3.19 M(-30.1%) | -$7.76 M(+69.9%) |
| Sept 2023 | - | -$4.56 M(-69.1%) | -$4.56 M(-57.7%) |
| Dec 2022 | -$39.76 M(+5.4%) | - | - |
| June 2022 | - | -$14.79 M(+42.5%) | -$10.79 M(-370.3%) |
| Mar 2022 | - | -$10.38 M(-139.3%) | $3.99 M(-64.9%) |
| Dec 2021 | -$37.70 M | $26.40 M(-319.7%) | $11.36 M(-174.0%) |
| Sept 2021 | - | -$12.01 M(>+9900.0%) | -$15.34 M(+244.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | -$14.41 K(-99.5%) | -$4.45 M(-4.6%) |
| Mar 2021 | - | -$3.02 M(+933.5%) | -$4.67 M(+170.0%) |
| Dec 2020 | -$2.27 M(+185.7%) | -$291.73 K(-74.2%) | -$1.73 M(+1.7%) |
| Sept 2020 | - | -$1.13 M(+390.3%) | -$1.70 M(+173.5%) |
| June 2020 | - | -$230.46 K(+201.5%) | -$621.28 K(+8.7%) |
| Mar 2020 | - | -$76.43 K(-70.8%) | -$571.47 K(-27.9%) |
| Dec 2019 | -$792.73 K | -$262.07 K(+401.0%) | -$792.73 K(+49.4%) |
| Sept 2019 | - | -$52.31 K(-71.0%) | -$530.66 K(+10.9%) |
| June 2019 | - | -$180.65 K(-39.3%) | -$478.34 K(+60.7%) |
| Mar 2019 | - | -$297.70 K | -$297.70 K |
FAQ
- What is NRx Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual CFO year-on-year change?
- What is NRx Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly CFO year-on-year change?
- What is NRx Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals TTM CFO year-on-year change?
What is NRx Pharmaceuticals annual cash flow from operations?
The current annual CFO of NRXPW is -$21.66 M
What is the all time high annual CFO for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual cash flow from operations is -$792.73 K
What is NRx Pharmaceuticals annual CFO year-on-year change?
Over the past year, NRXPW annual cash flow from operations has changed by +$18.10 M (+45.52%)
What is NRx Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of NRXPW is -$2.31 M
What is the all time high quarterly CFO for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly cash flow from operations is $26.40 M
What is NRx Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, NRXPW quarterly cash flow from operations has changed by +$2.26 M (+49.47%)
What is NRx Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of NRXPW is -$11.73 M
What is the all time high TTM CFO for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high TTM cash flow from operations is $11.36 M
What is NRx Pharmaceuticals TTM CFO year-on-year change?
Over the past year, NRXPW TTM cash flow from operations has changed by -$7.17 M (-157.03%)